Home Suppliers FDA CDER Small Business and Industry Assistance (SBIA) Featured Content M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms -- Implementing the Final Guidance - Webinar

Overview Activity & Updates Locations Contacts

Back

No Feature content logo

M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms -- Implementing the Final Guidance - Webinar

Posted by
William

242 days ago

This webinar will provide an update and overview on the final M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms guideline including major changes from the draft guideline and FDA’s current bioequivalence (BE) guidance, delineate FDA’s planning on the implementation of M13A, and address questions and provide clarifications based on questions/comments received during public consultation of the draft guideline.

Register here ➡️ M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms -- Implementing the Final Guidance - 11/21/2024 | FDA⁠⁠⁠⁠⁠⁠⁠

Show More
Get Your Copy
Please fill out the required information.

First Name is required.
Last Name is required.
Business Email is required.
Job Title is required.
Company Name is required.